Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Low-Level Laser Irradiation Exerts Antiaggregative Effect on Human Platelets Independently on the Nitric Oxide Metabolism and Release of Platelet Activation Markers

We have demonstrated in the established in vitro experimental model that the LLLT in a reproducible manner decreases the whole blood platelet aggregation regardless of the NO bioavailability or changes in the platelet activation markers.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors exposed human platelets from 41 healthy volunteers to red laser light at 662 nm and then measured platelet aggregation in response to three agonists. All tested doses reduced aggregation, with the strongest effect at 19.7 J/cm2, while levels of platelet activation markers and nitric oxide pathway compounds did not differ significantly between groups. The study was an in vitro experimental model, so the findings do not directly show effects in living people.

Participants
41
Who or what was studied
41 healthy volunteers aged 21 to 45 years, with platelets tested in vitro
Wavelengths
662 nm
Limits stated in the abstract
The study was conducted in an in vitro experimental model in healthy volunteers, which limits direct clinical application.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Aim

The goal of the study is to develop a model allowing to investigate precisely the effect of low-level laser therapy (LLLT) on platelet aggregation and to verify the hypothesis regarding the role of the nitric oxide (NO) bioavailability and platelet activation markers in modulating platelet aggregation.

Methods

A total of 41 healthy volunteers at the age of 21-45 years were investigated. At first, platelet aggregation in response to three agonists (TRAP, ADP, and collagen) was evaluated following previous exposure to different doses of laser radiation (λ = 662 nm) to assess the dose-response effect. Subsequently, plasma levels of platelet activation markers (PF4-platelet factor-4 and sP-selectin) as well as the substrate for nitric oxide synthase, L-arginine, and its competitive inhibitors (ADMA-asymmetric dimethylarginine and SDMA-symmetric dimethylarginine) were measured.

Results

All doses of laser irradiation significantly reduced the aggregation. However, the most pronounced effect was observed for 19.7 J/cm2. No significant differences in the levels of platelet activation markers nor in the nitric-oxide-metabolic-pathway compounds between analyzed groups were noted.

Conclusions

We have demonstrated in the established in vitro experimental model that the LLLT in a reproducible manner decreases the whole blood platelet aggregation regardless of the NO bioavailability or changes in the platelet activation markers.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
662 nm
Energy density (fluence)
19.7 J/cm2

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Laser, Nitric oxide, Low-level laser therapy, Collagen, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies